400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Others / Galectin-3 / (2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol)
CAS No.: 1450824-22-2
Synonyms: GB0-139;半乳凝素-3抑制剂
TD139 is an inhibitor of the galectin-3 carbohydrate binding domain with Kd of 14 nM and shows therapeutic efficacy against idiopathic pulmonary fibrosis (IPF).
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02257177 | Idiopathic Pulmonary Fibrosis | Phase 1 Phase 2 | Completed | - | United Kingdom ... more >> Royal Devon & Exeter Foundation NHS Trust Exeter, Devon, United Kingdom, EX2 5DW Edinburgh University Hospital Edinburgh, Scotland, United Kingdom, EH16 4SA The Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle, Tyne and Wear, United Kingdom, NE3 3HD Simbec Research Limited Merthyr Tydfil, Wales, United Kingdom, CF48 4DR Royal Brompton Hospital London, United Kingdom, SW3 6NP Collapse << |
实验方案
技术信息
CAS号 | 1450824-22-2 | 储存条件 |
|
|||||||||
分子式 | C28H30F2N6O8S | 运输 | 蓝冰 | |||||||||
分子量 | 648.64 | 别名 | GB0-139;半乳凝素-3抑制剂 | |||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02257177 | Idiopathic Pulmonary Fibrosis | Phase 1 Phase 2 | Completed | - | United Kingdom ... more >> Royal Devon & Exeter Foundation NHS Trust Exeter, Devon, United Kingdom, EX2 5DW Edinburgh University Hospital Edinburgh, Scotland, United Kingdom, EH16 4SA The Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle, Tyne and Wear, United Kingdom, NE3 3HD Simbec Research Limited Merthyr Tydfil, Wales, United Kingdom, CF48 4DR Royal Brompton Hospital London, United Kingdom, SW3 6NP Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网